Brain γ-Aminobutyric Acid Abnormality in Tardive Dyskinesia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (89)
(–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
1980 • 1,091 citations
Tardive Dyskinesia
1982 • 660 citations
The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay
1981 • 545 citations
The influence of fatigue on health-related quality of life in patients with Parkinson's disease
2003 • 439 citations
Evidence for a gabaergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat
1979 • 397 citations
Simultaneous Determination of 3,4‐Dihydroxyphenylalanine, 5‐Hydroxytryptophan, Dopamine, 4‐Hydroxy‐3‐Methoxyphenylalanine, Norepinephrine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, Serotonin, and 5‐Hydroxyindoleacetic Acid in Rat Cerebrospinal Fluid and Brain by High‐Performance Liquid Chromatography with Electrochemical Detection
1982 • 350 citations
Spontaneous Involuntary Disorders of Movement
1982 • 338 citations
Evidence for the participation of nigrotectal γ-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat
1982 • 318 citations
On the source of gaba-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies
1973 • 286 citations
An experimental model of tardive dyskinesia
1972 • 276 citations
Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems
1984 • 273 citations
GABA levels in CSF of patients with psychiatric disorders
1980 • 263 citations
Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis
1984 • 252 citations
CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa
1981 • 251 citations
Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia
1974 • 245 citations
Intranigral kainic acid is evidence that nigral non-dopaminergic neurones control posture
1977 • 243 citations
EXPERIMENTAL HEMICHOREA/ HEMIBALLISMUS IN THE MONKEY
1984 • 209 citations
The nigrotectal projection: a biochemical and ultrastructural characterization
1978 • 193 citations
Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra
1973 • 193 citations
The Pathophysiologic Basis of Tardive Dyskinesia
1980 • 190 citations
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications
1981 • 154 citations
CONCENTRATION OF HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID AFTER TREATMENT WITH PROBENECID IN PATIENTS WITH DRUG‐INDUCED TARDIVE DYSKINESIA
1970 • 143 citations
Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia
1983 • 140 citations
The distribution and some morphological features of substantia nigra neurons that project to the thalamus, superior colliculus and pedunculopontine nucleus in the monkey
1982 • 138 citations
Biological substrates of schizophrenia
2009 • 128 citations
Improvement in Tardive Dyskinesia After Muscimol Therapy
1979 • 123 citations
Increased gamma-aminobutyric acid (GABA), homocarnosine and β-alanine in cerebrospinal fluid of patients treated with γ-vinyl GABA (4-amino-hex-5-enoic acid)
1981 • 119 citations
Effect of Sodium Valproate on Tardive Dyskinesia
1976 • 118 citations
Long-Term Treatment of Tardive Dyskinesia with Haloperidol and Tetrabenazine
1973 • 116 citations
The effect of chronic neuroleptic administration on cerebral dopamine receptor function
1983 • 113 citations
Muscimol: GABA agonist therapy in schizophrenia
1978 • 113 citations
Paradoxical response to dopamine agonists in tardive dyskinesia
1977 • 112 citations
Incidence of tardive dyskinesia: five-year data from a prospective study.
1984 • 112 citations
γ-Acetylenic GABA in Tardive Dyskinesia
1980 • 111 citations
Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra
1980 • 110 citations
Free and conjugated amino acids in human CSF: Influence of age and sex
1985 • 108 citations
Abnormal Involuntary Movements in Schizophrenia
1982 • 104 citations
Neurochemical analysis of cerebrospinal fluid
1980 • 103 citations
Turnover times of gamma-aminobutyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol
1977 • 103 citations
Substantia nigra as an out-put station for striatal dopaminergic responses: Role of a GABA-mediated inhibition of pars reticulata neurons
1979 • 102 citations
In Search of Treatment for Tardive Dyskinesia: Review of the Literature*
1979 • 94 citations
A Neuroendocrine Study of Supersensitivity in Tardive Dyskinesia
1977 • 90 citations
Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias
1972 • 84 citations
Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation
1978 • 84 citations
γ-aminobutyric acidB receptors in the rat brain: Quantitative autoradiographic localization using [3H](−)-baclofen
1985 • 70 citations
Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: Evidence for both pre- and post-synaptic inhibition of catecholamine systems
1977 • 69 citations
Baclofen (Lioresal®) in the treatment of neuroleptic‐induced tardive dyskinesia
1976 • 67 citations
Stability of GABA levels in CSF under various conditions of storage
1980 • 67 citations
Effect of baclofen on tardive dyskinesia
1978 • 65 citations
Depression as a risk factor in tardive dyskinesia.
1982 • 60 citations
The pharmacology of Amanita muscaria.
1967 • 55 citations
Intranigral gaba antagonists produce dopamine-independence biting in rats
1980 • 55 citations
Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
1975 • 52 citations
Evidence that the nigrotegmental GABAergic projection mediates stereotypy induced by apomorphine and intranigral muscimol
1983 • 52 citations
Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: Striatal dopamine and GABA-mediated responses of pars reticulata neurons
1983 • 51 citations
The Effect of Tetrahydroisoxazolopyridinol (THIP) in Tardive Dyskinesia
1982 • 49 citations
Gamma-Vinyl GABA
1985 • 47 citations
Triple-column ion-exchange physiological amino acid analysis with fluorescent detection: Baseline characterization of human cerebrospinal fluid
1984 • 43 citations
Effect of gamma-vinyl GABA in tardive dyskinesia
1983 • 42 citations
Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders
1985 • 42 citations
Anomalous behavioral response to imidazoleacetic acid, a GABA agonist, in animals treated chronically with haloperidol.
1980 • 39 citations
Baclofen in the treatment of tardive dyskinesia
1978 • 36 citations
GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions
1981 • 36 citations
Strategy for the study of patients at high risk for tardive dyskinesia
1980 • 35 citations
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents.
1983 • 33 citations
Gabaergic actions of thip in vivo and in vitro: A comparison with muscimol an GABA
1980 • 33 citations
Effect of haloperidol on glutamete decarboxylase activity in discrete brain areas of the rat
1983 • 32 citations
The locomotor-reducing effects of GABAergic drugs do not depend on the GABAA receptor
1985 • 32 citations
Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
1978 • 32 citations
Chronic neuroleptic therapy: tolerance and GABA systems.
1977 • 30 citations
The treatment of tardive dyskinesia with baclofen
1985 • 29 citations
Sodium Valproate and Tardive Dyskinesia
1978 • 29 citations
Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
1982 • 26 citations
State-dependent tardive dyskinesia in manic-depressive illness.
1983 • 26 citations
Gamma‐vinyl GABA treatment of Huntington's disease
1984 • 26 citations
Suppression of apomorphine-induced oral stereotypy in rats by microinjection of muscimol into midbrain
1982 • 26 citations
Baclofen in the treatment of tardive dyskinesia and schizophrenia.
1978 • 25 citations
[Pharmacological and experimental psychological studies with 2 components of fly agaric (Amanita muscaria)].
1968 • 22 citations
Further Characterization of In Vitro Conditions Appropriate for GABA Determination in Human CSF: Impact of Acid Deproteinization and Freeze/Thaw
1983 • 19 citations
Pharmacological Modification of Experimental Tardive Dyskinesia
1979 • 18 citations
THIP, isoguvacine, isoguvacine oxide, and related GABA agonists.
1981 • 18 citations
State-Related Cyclical Dyskinesias in Manic-Depressive Illness
1982 • 16 citations
Gamma-Acetylenic GABA in tardive dyskinesia.
1980 • 15 citations
Autoradiographic localization of binding sites for the γ-aminobutyric acid analogues 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP)isoguvacine and baclofen on cultured neurons of rat cerebellum and spinal cord
1985 • 14 citations
Clinical Implications of Enzyme-Mediated Alterations of -Aminobutyric Acid Content in Human CSF
1981 • 13 citations
The role of GABA in dyskinesias induced by chemical stimulation of the striatum
1977 • 13 citations
GABA: AN ESSENTIAL MODERATOR AND MEDIATOR IN THE BASAL GANGLIA SYSTEM OF DOPAMINE RELATED FUNCTIONS.
2009 • 12 citations
Geriatric psychopharmacology: clinical evaluation of brain function in the aged.
1978 • 4 citations
Combination Treatment of Choreiform and Dyskinetic Syndromes with Tetrabenazine and Pimozide
1980 • 4 citations